Incidences of rare blood clot in four U.S residents after J&J COVID-19 vaccine shots, has urged the country to halt the administration of these vaccines for a temporary time period. This has also produced a delay i

The investment will re-affirm the startup’s patient-centric approach to understand interaction with the healthcare system and offer an enhanced analytic platform

Researchers at the George Washington University have established that a low dose of aspirin may help reduce the need for ICU admission, mechanical ventilation, and in-hospital mortality in patients suffering from the n

Graphite Bio, a San Francisco-based next-generation gene editing company that focuses on treating chronic diseases, has reportedly announced that it has secured funds worth $150 million through a Series B Funding round

American pharmaceutical giant- Pfizer has reportedly announced that the U.S. Food and Drug Administration (FDA) has sanctioned the use of a supplemental NDA (new drug application) for Lorbrena or lorlatinib, that expands the indication of the drug to

Israel-based SciSparc Ltd.- a clinical-stage pharmaceutical firm that develops cannabinoid-based treatment solutions, has reportedly announced that it has entered into an agreement with the Israeli Medical Center for Alzheimer’s to facilitate